Xiangming Mao

537 total citations
20 papers, 360 citations indexed

About

Xiangming Mao is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangming Mao has authored 20 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangming Mao's work include Urinary and Genital Oncology Studies (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and MicroRNA in disease regulation (3 papers). Xiangming Mao is often cited by papers focused on Urinary and Genital Oncology Studies (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and MicroRNA in disease regulation (3 papers). Xiangming Mao collaborates with scholars based in China and United States. Xiangming Mao's co-authors include Kaihui Wu, Taowei Yang, Wenbin Chen, Xumin Zhou, Junqi Luo, Chuanyin Li, Libin Zou, Xiao Tan, Fangpeng Shu and Jianming Lü and has published in prestigious journals such as Free Radical Biology and Medicine, Cell Death and Disease and Pharmacological Research.

In The Last Decade

Xiangming Mao

19 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangming Mao China 11 214 173 112 56 31 20 360
Lujia Zou China 10 182 0.9× 127 0.7× 92 0.8× 108 1.9× 43 1.4× 26 353
Guangcheng Dai China 12 185 0.9× 108 0.6× 155 1.4× 44 0.8× 24 0.8× 31 376
Jikai Liu China 10 160 0.7× 83 0.5× 74 0.7× 127 2.3× 52 1.7× 21 331
Cong Huang China 13 154 0.7× 74 0.4× 97 0.9× 35 0.6× 50 1.6× 31 312
Jungang Zhao China 11 278 1.3× 218 1.3× 130 1.2× 65 1.2× 60 1.9× 23 407
Haifeng Wang China 10 153 0.7× 62 0.4× 127 1.1× 98 1.8× 53 1.7× 43 357
Kristina Daniūnaitė Lithuania 13 347 1.6× 263 1.5× 166 1.5× 41 0.7× 65 2.1× 23 506
Yidong Cheng China 13 409 1.9× 330 1.9× 51 0.5× 122 2.2× 35 1.1× 24 539
Xiaodong Yu China 12 294 1.4× 249 1.4× 69 0.6× 50 0.9× 80 2.6× 26 449
Xueqiong Zhou China 8 153 0.7× 73 0.4× 107 1.0× 17 0.3× 28 0.9× 12 306

Countries citing papers authored by Xiangming Mao

Since Specialization
Citations

This map shows the geographic impact of Xiangming Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Mao more than expected).

Fields of papers citing papers by Xiangming Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangming Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Mao. The network helps show where Xiangming Mao may publish in the future.

Co-authorship network of co-authors of Xiangming Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangming Mao. A scholar is included among the top collaborators of Xiangming Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangming Mao. Xiangming Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shuo, Genshan Ma, Cancan Qi, et al.. (2025). Trimethylamine-N-oxide disrupts spermatogenesis by inducing mitochondrial oxidative stress injury through Hippo signaling. Free Radical Biology and Medicine. 243. 452–465.
2.
Zhong, Chuanfan, Jianming Lü, Zining Long, et al.. (2024). GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer. Cell Communication and Signaling. 22(1). 600–600. 2 indexed citations
3.
Zhou, Xumin, Jiaqi Wang, Yufei Guo, et al.. (2024). Water extract of sporoderm-broken spores of Ganoderma lucidum elicits dual antitumor effects by inhibiting p-STAT3/PD-L1 and promoting ferroptosis in castration-resistant prostate cancer. Journal of Functional Foods. 113. 106018–106018. 2 indexed citations
4.
Chen, Wenbin, Zhao Zhang, Shengren Cen, et al.. (2023). Exposure to elevated temperature affects the expression of PIWI‐interacting RNAs and associated transcripts in mouse testes. Andrology. 11(4). 724–737. 5 indexed citations
5.
Su, Xiaohong, Chuanyin Li, Kai Xu, et al.. (2022). The Effect of Prostate Cancer-Targeting Doxorubicin Nanomicelles Combined with Photothermal Therapy on Castration-Resistant Prostate Cancer. Journal of Biomedical Nanotechnology. 18(5). 1276–1288. 1 indexed citations
6.
Zhong, Chuanfan, Kaihui Wu, Shuo Wang, et al.. (2021). Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell Death and Disease. 12(8). 726–726. 27 indexed citations
7.
Tan, Xiao, Wenbin Chen, Daojun Lv, et al.. (2021). LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. Cell Death and Disease. 12(2). 138–138. 40 indexed citations
8.
Chen, Wenbin, Shengren Cen, Xumin Zhou, et al.. (2021). Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis. Frontiers in Cell and Developmental Biology. 8. 624764–624764. 41 indexed citations
9.
10.
Shu, Fangpeng, Taowei Yang, Xuefeng Zhang, et al.. (2021). Hyaluronic acid modified covalent organic polymers for efficient targeted and oxygen-evolved phototherapy. Journal of Nanobiotechnology. 19(1). 4–4. 20 indexed citations
11.
12.
Zhou, Xumin, Libin Zou, Wenbin Chen, et al.. (2020). Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological Research. 164. 105305–105305. 73 indexed citations
13.
Wang, Shuo, Wei Su, Chuanfan Zhong, et al.. (2020). An Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer. Frontiers in Cell and Developmental Biology. 8. 599494–599494. 84 indexed citations
14.
15.
Wu, Xiaoqiang, Shuo Wang, Xumin Zhou, et al.. (2020). Microstructures of the spermatic cord with three-dimensional reconstruction of sections of the cord and application to varicocele. Systems Biology in Reproductive Medicine. 66(3). 216–222. 3 indexed citations
16.
Tan, Xiao, Daojun Lv, Fangpeng Shu, et al.. (2019). Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis. Journal of Cancer. 11(5). 1027–1037. 12 indexed citations
17.
Li, Bingkun, et al.. (2019). [Video endosopic inguinal lymphadenectomy for penile cancer].. PubMed. 25(9). 848–851. 1 indexed citations
18.
Zhang, Zhao, Ning Sun, & Xiangming Mao. (2018). Vascularization of vessel pedicle in hypospadias and its relationship to near‑period complications. Experimental and Therapeutic Medicine. 16(3). 2408–2412. 5 indexed citations
19.
Yuan, Haichao, Xiangming Mao, Yunjin Bai, et al.. (2015). The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis. Journal of Chemotherapy. 27(4). 195–200. 12 indexed citations
20.
Chen, Zhuangfei, et al.. (2010). [Synchronous squamous cell carcinoma of the renal pelvis and squamous cell carcinoma of the ureter: report of two cases and review of literature].. PubMed. 30(12). 2765–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lujia Zou Breakdown of academic impact, for papers by Guangcheng Dai Breakdown of academic impact, for papers by Jikai Liu Breakdown of academic impact, for papers by Cong Huang Breakdown of academic impact, for papers by Jungang Zhao Breakdown of academic impact, for papers by Haifeng Wang Breakdown of academic impact, for papers by Kristina Daniūnaitė Breakdown of academic impact, for papers by Yidong Cheng Breakdown of academic impact, for papers by Xiaodong Yu Breakdown of academic impact, for papers by Xueqiong Zhou
Rankless by CCL
2026